Changes of PTH, 1,25(OH)2D3 and Biochemistry in Renal Osteodystrophy.

被引:0
|
作者
Jia Jing-kang
33(1):33.
机构
关键词
Changes of PTH; OH; and Biochemistry in Renal Osteodystrophy; HTO; LTO;
D O I
暂无
中图分类号
R681 [骨骼疾病];
学科分类号
1002 ; 100210 ;
摘要
The changes of plasma PTH, 1,25(OH)D, serum calcium, phosphorus and AKP were observed in 55 uremic patients with renal osteodystrophy. The results showed that: in all types of renal osteodystrophy, plasma PTH were markedly higher than normal (P<0.001), while plasma 1,25(OHH)Dand serum calcium were lower than normal (P<0.001). In low bone-turnover uremic osteodystrophy (LTO), plasma phosphorus was markedly lower than that of high bone-turnover uremic osteodystrophy (HTO) and mixe d uremic osteodystrophy (MO) (P<0.05), and plasma 1,25(OH)Dwas significantly lower than that of HTO (P<0.05). In HTO and MO, serum phosphorus was much higher than mormal (P<0.001). Plasma PTH had a negative linear correlation with plasma 1,25(OH)D(P<0.05), a positive linear correlation with serum AKP (P<0.05), but no linear correlation with the duration of hemodialysis, serum calcium, serum aluminum and bone aluminum content. Plasma 1.25(OH)Dhad no linear correlation with the duration of hemodialysis, seru
引用
收藏
页码:21 / 21
页数:1
相关论文
共 50 条
  • [1] CHANGES OF PTH,1,25(OH)2D3 AND BIOCHEMISTRY IN RENAL OSTEODYSTROPHY
    JIA, JK
    LOU, DX
    ZHU, B
    WANG, GY
    CHAO, HT
    DONG, DC
    [J]. KIDNEY INTERNATIONAL, 1992, 42 (02) : 499 - 499
  • [2] EFFECT OF 1,25(OH)2D3 IN PATIENTS WITH RENAL OSTEODYSTROPHY
    CHRISTIANSEN, C
    HARTNACK, B
    NAESTOFT, J
    TRANSBOL, I
    [J]. KIDNEY INTERNATIONAL, 1978, 14 (06) : 637 - 637
  • [3] 1,25(OH)2D3 AND 25-OHD3 IN THE TREATMENT OF RENAL OSTEODYSTROPHY - COMPARISON OF COMBINED VERSUS 1,25(OH)2D3 ADMINISTRATION ALONE
    COEN, G
    GALLUCCI, MT
    BONUCCI, E
    BALLANTI, P
    BIANCHI, AR
    BIANCHINI, G
    MATTEUCCI, MC
    MAZZAFERRO, S
    PICCA, S
    TAGGI, F
    CINOTTI, GA
    CASCIANI, CU
    [J]. MINERAL AND ELECTROLYTE METABOLISM, 1983, 9 (01) : 19 - 27
  • [4] EFFECTS OF 1,25(OH)2D3 ON RENAL OSTEODYSTROPHY AND GROWTH IN HEMODIALYZED CHILDREN
    POPOVICROLOVIC, M
    JOVANOVIC, O
    RADMANOVIC, S
    NEGOVANOVIC, D
    CALICPERISIC, N
    LEZAJIC, V
    [J]. INTERNATIONAL JOURNAL OF PEDIATRIC NEPHROLOGY, 1982, 3 (02): : 139 - 139
  • [5] CURRENT STATUS OF THE USE OF 1,25(OH)2D3 IN THE MANAGEMENT OF RENAL OSTEODYSTROPHY
    MASSRY, SG
    GOLDSTEIN, DA
    MALLUCHE, HH
    [J]. KIDNEY INTERNATIONAL, 1980, 18 (04) : 409 - 418
  • [6] EFFECT OF 1,25(OH)2D3 IN PATIENTS WITH RENAL OSTEODYSTROPHY A CONTROLLED THERAPEUTIC TRIAL
    CHRISTIANSEN, C
    HARTNACK, B
    NAESTOFT, J
    TRANSBOL, I
    [J]. AMERICAN JOURNAL OF ROENTGENOLOGY, 1978, 131 (03) : 545 - 545
  • [7] 24,25(OH)2D3 IN COMBINATION WITH 1,25(OH)2D3 AMELIORATES RENAL OSTEODYSTROPHY IN RATS WITH CHRONIC RENAL-FAILURE (CRF)
    RUBINGER, D
    MOSCOVITZ, A
    POPOVTZER, MM
    BAB, I
    GAZIT, D
    [J]. KIDNEY INTERNATIONAL, 1989, 35 (01) : 379 - 379
  • [8] SYNERGIC EFFECT OF 250HD3 AND 1,25(OH)2D3 IN RENAL OSTEODYSTROPHY IS UNRELATED TO 24,25(OH)2D3 LEVELS
    COEN, G
    GALLUCCI, T
    BONUCCI, E
    BALLANTI, P
    MATTEUCCI, MC
    BIANCHI, AR
    BIANCHINI, G
    PICCA, S
    CINOTTI, GA
    CASCIANI, CU
    [J]. ARTIFICIAL ORGANS, 1981, 5 (02) : 193 - 193
  • [9] TREATMENT OF RENAL OSTEODYSTROPHY (ROD) WITH 25-OHD3 AND 1,25 (OH)2D3 - SYNERGIC EFFECT UNRELATED TO 24,25(OH)2D3 SYNTHESIS
    COEN, G
    GALLUCCI, MT
    BONUCCI, E
    BALLANTI, P
    BIANCHI, AR
    MATTEUCCI, MC
    PICCA, S
    BIANCHINI, G
    MAZZAFERRO, S
    CINOTTI, GA
    CASCIANI, CU
    [J]. KIDNEY INTERNATIONAL, 1982, 22 (01) : 96 - 96
  • [10] 1,25(OH)2D3 AND RENAL-FUNCTION
    JENSEN, GF
    CHRISTIANSEN, C
    TRANSBOL, I
    [J]. ACTA MEDICA SCANDINAVICA, 1982, 211 (1-2): : 51 - 54